UPM is entering the world of 3D printing, offering novel non-animal derived, ready-to-use hydrogels which mimic the in vivo environment to support cell growth and differentiation. The new GrowInk™ Bioinks product range is ideal for a wide range of bioprinting applications, including cell encapsulation and scaffold preparation for tissue engineering, drug discovery and regenerative medicine. For more information see the IDTechEx report on 3D Bioprinting 2018 - 2028: Technologies, Markets, Forecasts.
The two main components of GrowInk Bioinks - nanofibrillar cellulose and water - provide a fully defined matrix that can be mixed directly with cells and customised with additional growth factors or adhesion proteins. Compatible with a large variety of 3D printers, GrowInk Bioinks have been developed to provide exceptional imaging quality, presenting an opportunity to revolutionise research in this area.
UPM's GrowDex® product range is also expanding, with a new sterile hydrogel - GrowDex-A - containing avidin-conjugated nanofibrillar cellulose. The product has been specifically developed to bind biotinylated molecules including proteins, peptides and antibiotics, and is suitable for use in various applications, such as spheroid formation for 3D cell culture.
Source and top image: UPM Biomedicals
Learn more at the next leading event on the topic: 3D Printing & 3D Electronics Europe 2020 on 13 - 14 May 2020 at Estrel Convention Center, Berlin, Germany hosted by IDTechEx.